A systematic review of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer.

Muscle-invasive bladder cancer (MIBC) is a disease with a pattern of predominantly distant and early recurrences. Neoadjuvant cisplatin-based combination chemotherapy has demonstrated improved outcomes for MIBC.